Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Interventional
×
pegilodecakin
×
Clear all
Filters
3
NCT03382899
2021-01-20
Cypress 1
Eli Lilly and Company
Phase 2
Terminated
101 enrolled
15 charts
NCT03382912
2020-09-11
Cypress 2
Eli Lilly and Company
Phase 2
Terminated
52 enrolled
15 charts